MY131308A - Pharmaceutical products comprising androgen receptor antagonist useful in the treatment of androgen-exacerbated diseases - Google Patents
Pharmaceutical products comprising androgen receptor antagonist useful in the treatment of androgen-exacerbated diseasesInfo
- Publication number
- MY131308A MY131308A MYPI93000969A MYPI9300969A MY131308A MY 131308 A MY131308 A MY 131308A MY PI93000969 A MYPI93000969 A MY PI93000969A MY PI9300969 A MYPI9300969 A MY PI9300969A MY 131308 A MY131308 A MY 131308A
- Authority
- MY
- Malaysia
- Prior art keywords
- androgen
- treatment
- receptor antagonist
- pharmaceutical products
- antagonist useful
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88696192A | 1992-05-21 | 1992-05-21 | |
US6061293A | 1993-05-17 | 1993-05-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY131308A true MY131308A (en) | 2007-08-30 |
Family
ID=26740118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI93000969A MY131308A (en) | 1992-05-21 | 1993-05-21 | Pharmaceutical products comprising androgen receptor antagonist useful in the treatment of androgen-exacerbated diseases |
Country Status (6)
Country | Link |
---|---|
US (1) | US6015806A (en) |
AU (1) | AU680818B2 (en) |
IL (1) | IL105767A0 (en) |
MY (1) | MY131308A (en) |
NO (1) | NO306162B1 (en) |
NZ (2) | NZ329795A (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294188B1 (en) | 1998-07-09 | 2001-09-25 | Aviana Biopharm Inc. | Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women |
WO2001023405A2 (en) | 1999-09-30 | 2001-04-05 | Hollis-Eden Pharmaceuticals, Inc. | Therapeutic treatment of androgen receptor driven conditions |
CA2472475C (en) * | 2002-01-15 | 2010-05-18 | Merck & Co., Inc. | 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
CN100473660C (en) * | 2002-03-22 | 2009-04-01 | 法玛西雅厄普约翰美国公司 | Process for preparing eplerenone |
AU2003254261B2 (en) * | 2002-07-30 | 2008-04-17 | Children's Medical Center Corporation | Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1081494A (en) * | 1965-09-14 | 1967-08-31 | British Drug Houses Ltd | 17ª-(alka-1',3'-diynyl)-steroids |
US3875188A (en) * | 1968-04-10 | 1975-04-01 | Eugene E Galantay | 17-Beta-alpha-lower alkyl allene-substituted steroids |
US4039669A (en) * | 1975-08-01 | 1977-08-02 | Sterling Drug Inc. | Composition for topical application and use thereof |
FR2430952A1 (en) * | 1978-07-13 | 1980-02-08 | Roussel Uclaf | NOVEL ACETYLENIC DERIVATIVES OF ANDROST 4-ENE, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS A MEDICAMENT |
AU584070B2 (en) * | 1983-12-12 | 1989-05-18 | Edwin G. Kaszynski | Hair growth modification |
IE60780B1 (en) * | 1987-01-23 | 1994-08-10 | Akzo Nv | New 11-aryl steroid derivatives |
US4888336A (en) * | 1987-01-28 | 1989-12-19 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
JP2591640B2 (en) * | 1988-02-04 | 1997-03-19 | 帝国臓器製薬株式会社 | Novel 2-oxapregnane compound |
EP0334425A1 (en) * | 1988-03-24 | 1989-09-27 | Akzo N.V. | Novel delta4 - androstene derivatives |
US5364847A (en) * | 1989-03-10 | 1994-11-15 | Endorecherche | Inhibitors of sex steroid biosynthesis and methods for their production and use |
KR0181264B1 (en) * | 1989-07-07 | 1999-03-20 | 라브리 페르낭 | Androgen derivatives for use in the inhibition of sex steroid activity |
EP0408442B1 (en) * | 1989-07-12 | 1994-08-31 | L'oreal | Halogenated pyrimidin-3-oxyde derivatives, their use for the treatment and the prevention of hairloss and for stimulating growth again |
-
1993
- 1993-05-20 AU AU40572/93A patent/AU680818B2/en not_active Ceased
- 1993-05-21 NZ NZ329795A patent/NZ329795A/en unknown
- 1993-05-21 IL IL105767A patent/IL105767A0/en unknown
- 1993-05-21 NZ NZ247669A patent/NZ247669A/en unknown
- 1993-05-21 MY MYPI93000969A patent/MY131308A/en unknown
-
1994
- 1994-11-21 NO NO944457A patent/NO306162B1/en not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/478,973 patent/US6015806A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NZ247669A (en) | 1997-01-29 |
AU680818B2 (en) | 1997-08-14 |
US6015806A (en) | 2000-01-18 |
NZ329795A (en) | 2000-02-28 |
AU4057293A (en) | 1994-12-12 |
NO944457D0 (en) | 1994-11-21 |
IL105767A0 (en) | 1993-09-22 |
NO306162B1 (en) | 1999-09-27 |
NO944457L (en) | 1994-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG19752A (en) | Dialkoxy-pyridinyl-benzimidazole derivatives process for their preparation and their pharmaceutical use | |
PL297747A1 (en) | Prolonged action pharmaceutical dosage forms | |
ZA928832B (en) | Local delivery of dipyridamole for the treatment of proliferative diseases | |
HUP9901092A3 (en) | Benzimidazole compounds and their pharmaceutical use | |
GB2247837B (en) | Pharmaceutical product for the treatment of immunoregulatory disorders | |
GB2255503B (en) | Improved use of ß2-bronchodilator drugs | |
OA09682A (en) | Substituted benzimidazoles process for their preparation and their pharmaceutical use | |
GB9200417D0 (en) | Cytotoxic drug therapy | |
LT96148A (en) | Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction | |
HUP9603607A3 (en) | Use of triazolidine derivatives for the preparation of pharmaceutical compositions for the treatment and prophylaxis of osteoporosis | |
ZA983602B (en) | Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination | |
LTIP249A (en) | Pharmaceutical composition and process for the preparation thereof | |
IL86302A0 (en) | Pharmaceutical combination for the prophylaxis and therapy of malaria | |
HUP0003244A2 (en) | Novel triptolide derivatives useful in the treatment of autoimmune diseases and pharmaceutical compositions thereof | |
MY131308A (en) | Pharmaceutical products comprising androgen receptor antagonist useful in the treatment of androgen-exacerbated diseases | |
ZA933426B (en) | New dihydroxybenzylamine derivatives their preparation and pharmaceutical compositions which contain them | |
IL117395A0 (en) | Bicyclic compounds preparation thereof and use in pharmaceutical compositions | |
ZA945892B (en) | Microparticles processes for their preparation and their use for the preparation of medicaments | |
GB9304745D0 (en) | Use of pharmaceutical formulations | |
ZA951789B (en) | Pharmaceutical materials and methods of administration | |
IL105690A0 (en) | Pharmaceutical compositions for the treatment of arrhythmia | |
ZA922354B (en) | Pharmaceutical composition and process for the preparation thereof | |
ZA925983B (en) | Pharmaceutical compositions for the treatment of skin disorders | |
PL298159A1 (en) | Pharmaceutical preparation | |
ZA949032B (en) | Substituted benzimidazole processes for preparation and its pharmaceutical use |